Reply to Wilson Et Al.: The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Caution
AuthID
P-019-TWM
P-019-TWM
© 2025 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service